BiomX

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

Felix Biotech

Felix Biotechnology develops engineered bacteriophage therapies to treat drug-resistant bacterial infections for patients with chronic diseases and partners in the skin care industry.

MRM Health

This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.

Human Biome

This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.

Apini Therapeutics

This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.

CytomX

This biopharmaceutical company develops conditionally activated antibody therapeutics for oncology patients and healthcare providers.